Published in Blood Weekly, May 18th, 2006
These stem cells represent an early developmental stage in which the blood cells have not yet committed to a specialized function. The JAK2 mutation is likely to be associated with the excessive production of red blood cells in the bone marrow which is characteristic of PV.
Catriona H.M. Jamieson, Moores Cancer Center, University of California, San Diego; key contributing Stanford...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.